دورية أكاديمية
TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform.
العنوان: | TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform. |
---|---|
المؤلفون: | Peiffer AL; Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48019, United States.; Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109, United States., Garlick JM; Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48019, United States.; Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States., Wu Y; Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States., Wotring JW; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States., Arora S; Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States., Harmata AS; Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States., Bochar DA; Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States., Stephenson CJ; Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States., Soellner MB; Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109, United States.; Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States., Sexton JZ; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States.; University of Michigan Medical School, Ann Arbor, Michigan 48109, United States., Brooks CL 3rd; Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109, United States.; Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.; Department of Biophysics, University of Michigan, Ann Arbor, Michigan 48109, United States., Mapp AK; Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48019, United States.; Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109, United States.; Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States. |
المصدر: | ACS medicinal chemistry letters [ACS Med Chem Lett] 2023 May 30; Vol. 14 (6), pp. 860-866. Date of Electronic Publication: 2023 May 30 (Print Publication: 2023). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Washington, D.C. : American Chemical Society |
مستخلص: | The COVID-19 pandemic has highlighted the need for new antiviral approaches because many of the currently approved drugs have proven ineffective against mitigating SARS-CoV-2 infections. The host transmembrane serine protease TMPRSS2 is a promising antiviral target because it plays a role in priming the spike protein before viral entry occurs for the most virulent variants. Further, TMPRSS2 has no established physiological role, thereby increasing its attractiveness as a target for antiviral agents. Here, we utilize virtual screening to curate large libraries into a focused collection of potential inhibitors. Optimization of a recombinant expression and purification protocol for the TMPRSS2 peptidase domain facilitates subsequent biochemical screening and characterization of selected compounds from the curated collection in a kinetic assay. In doing so, we identify new noncovalent TMPRSS2 inhibitors that block SARS-CoV-2 infectivity in a cellular model. One such inhibitor, debrisoquine, has high ligand efficiency, and an initial structure-activity relationship study demonstrates that debrisoquine is a tractable hit compound for TMPRSS2. Competing Interests: The authors declare no competing financial interest. (© 2023 American Chemical Society.) |
التعليقات: | Update of: bioRxiv. 2021 Mar 27:2021.03.22.436465. doi: 10.1101/2021.03.22.436465. (PMID: 33791707) |
References: | Genomics. 1997 Sep 15;44(3):309-20. (PMID: 9325052) J Chem Theory Comput. 2020 Jun 9;16(6):3910-3919. (PMID: 32374996) Nature. 2022 May;605(7909):340-348. (PMID: 35344983) J Comput Chem. 2003 Oct;24(13):1549-62. (PMID: 12925999) Protein Sci. 2009 May;18(5):1081-94. (PMID: 19388054) Nat Rev Microbiol. 2021 Mar;19(3):155-170. (PMID: 33116300) J Org Chem. 2004 Oct 15;69(21):7317-28. (PMID: 15471486) Proc Natl Acad Sci U S A. 2021 Oct 26;118(43):. (PMID: 34635581) J Virol. 2011 Jan;85(2):873-82. (PMID: 21068237) J Virol. 2013 Dec;87(23):12552-61. (PMID: 24027332) PLoS Pathog. 2013;9(12):e1003774. (PMID: 24348248) Crit Care Explor. 2020 Nov 16;2(11):e0284. (PMID: 33225308) Nat Rev Drug Discov. 2022 Jan;21(1):3-5. (PMID: 34857884) Cancer Discov. 2014 Nov;4(11):1310-25. (PMID: 25122198) Chem Sci. 2020 Nov 13;12(3):983-992. (PMID: 35382133) J Infect Public Health. 2020 Oct;13(10):1405-1414. (PMID: 32684351) ACS Pharmacol Transl Sci. 2021 Apr 02;4(3):1124-1135. (PMID: 34136758) Basic Clin Pharmacol Toxicol. 2021 Feb;128(2):204-212. (PMID: 33176395) EMBO J. 2021 Aug 16;40(16):e107821. (PMID: 34159616) Biochimie. 2017 Nov;142:1-10. (PMID: 28778717) J Comput Chem. 2009 Jul 30;30(10):1545-614. (PMID: 19444816) Cancer Res. 2001 Feb 15;61(4):1686-92. (PMID: 11245484) Viruses. 2021 Jan 14;13(1):. (PMID: 33466921) Cancer Discov. 2020 Jun;10(6):779-782. (PMID: 32276929) J Virol. 2010 Dec;84(24):12658-64. (PMID: 20926566) Nat Microbiol. 2021 Jul;6(7):899-909. (PMID: 33907312) ACS Pharmacol Transl Sci. 2020 Sep 07;3(5):997-1007. (PMID: 33062952) J Am Chem Soc. 1976 Aug 4;98(16):4770-7. (PMID: 950417) Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303. (PMID: 29788355) Expert Opin Drug Discov. 2022 Mar;17(3):231-246. (PMID: 35072549) Nat Chem Biol. 2022 Sep;18(9):963-971. (PMID: 35676539) Cell. 2021 Apr 29;184(9):2523. (PMID: 33930298) Nat Med. 2021 Apr;27(4):717-726. (PMID: 33664494) Mol Cell Biol. 2006 Feb;26(3):965-75. (PMID: 16428450) Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2021450118. (PMID: 33310900) mBio. 2022 Jun 28;13(3):e0089222. (PMID: 35532162) Cell. 2020 Apr 16;181(2):271-280.e8. (PMID: 32142651) J Pharmacol Exp Ther. 2020 Dec;375(3):510-521. (PMID: 33033171) |
معلومات مُعتمدة: | P30 CA046592 United States CA NCI NIH HHS; R35 GM130587 United States GM NIGMS NIH HHS; R35 GM136356 United States GM NIGMS NIH HHS |
تواريخ الأحداث: | Date Created: 20230607 Latest Revision: 20240729 |
رمز التحديث: | 20240729 |
مُعرف محوري في PubMed: | PMC10237299 |
DOI: | 10.1021/acsmedchemlett.3c00035 |
PMID: | 37284689 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1948-5875 |
---|---|
DOI: | 10.1021/acsmedchemlett.3c00035 |